A METHOD OF MODULATING NF- $G(K)B ACTIVITY

Details for Australian Patent Application No. 2002316796 (hide)

Owner LEO PHARMA A/S

Inventors OLSEN, Lone, Stengelshoj; MADSEN, Mogens, Winkel

Pub. Number AU-A-2002316796

PCT Number PCT/DK02/00352

PCT Pub. Number WO2002/094265

Priority 60/292,297 24.05.01 US

Filing date 24 May 2002

Wipo publication date 3 December 2002

International Classifications

A61K 031/44 - Non-condensed pyridines

A61K 031/675 - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61P 035/00 Antineoplastic agents

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/292,297 24.05.01 US

8 May 2003 Application Open to Public Inspection

  Published as AU-A-2002316796

11 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316797-A METHOD OF MANUFACTURING A REINFORCEMENT ELEMENT FOR A FLEXIBLE PIPELINE

2002316795-Combination medicament for treatment of neoplastic diseases containing cyanoguanidine IKK inhibitors and a second anti-neoplastic drug